Neuromics
We are in the business of supporting those we keep us well and alive longer. We specialize in providing reagents and methods for the Neuroscience, Stem Cell and Regenerative Medicine Research Community. We serve scientists doing basic research and drug discovery in Neurodegenerative Diseases, Pain, Autoimmune Diseases and Cancer. Our unique value is based on providing reagents that are thoroughly
05/27/2026
Check out the news on emerging cancer therapies from Neuromics friends at CliniSciences Group-https://tinyurl.com/New-Cancer-Therapies
Images: Breast Cancer Microenvironment
https://tinyurl.com/Breast-Cancer-CAFS-Cells
🔎Please consider following our Showcase Page-https://tinyurl.com/News-Neuromics
🧠 Please check out our AI Assistant-https://tinyurl.com/Check-out-AssayIQ
05/24/2026
Thank you for the post HHMI. This study is a key first step toward finding a cure for Dravet Syndrome.
Dravet syndrome is a rare, often fatal form of childhood epilepsy. New research from David Liu (Harvard University, Broad Institute of MIT and Harvard) & collaborators found that a single dose of base editing can correct its underlying mutation in mice, dramatically reducing seizures & extending survival. “This study gives us hope that base editing could be an effective approach for durably correcting the underlying cause of Dravet syndrome in patients,” Liu says. bit.ly/4nLvIAM
Image: Mouse neurons courtesy of Christophe Leterrier, NeuroCyto Lab, INP, Marseille, France, via NIH BRAIN Initiative.
Precision DNA editing targets root cause of severe childhood epilepsy in preclinical study Study in mice shows that base editing can correct the genetic mutation behind Dravet syndrome
Click here to claim your Sponsored Listing.
Website
Address
5325 West 74th Street Suite 8
Edina, MN
55439
Opening Hours
| Monday | 8am - 5pm |
| Tuesday | 8am - 5pm |
| Wednesday | 8am - 5pm |
| Thursday | 8am - 5pm |
| Friday | 8am - 5pm |